Biblio Discovery — Demo Discovery Service

2 hasil untuk "Rachel Moate"

Menampilkan 1–2 · 0,40 detik · RSS

  1. Artikel Jurnal

    FRONTIER-3: a randomised phase 2a study to investigate tozorakimab, an anti-interleukin-33 monoclonal antibody, in early-onset asthma

    Jonathan Corren; Fred Reid; Rachel Moate dkk.

    ERJ Open Research, Vol. 12 No. 1 · 2026 · Inggris · DOAJ Scopus

    Background Interleukin (IL)-33 is implicated in the initiation and progression of asthma. FRONTIER-3 (NCT04570657) was a phase 2a study to investigate tozorakimab, an anti-IL-33 monoclonal antibody, in adults with moderate-to-severe early-onset asthma receiving standard of care. Methods Patients…

  2. Artikel Jurnal

    A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2

    Tom Wilkinson; Anthony De Soyza; Miles Carroll dkk.

    ERJ Open Research, Vol. 9 No. 5 · 2023 · Inggris · DOAJ Scopus

    Background Increased serum interleukin (IL)-33 predicts poor outcomes in patients hospitalised with coronavirus disease 2019 (COVID-19). We examined the efficacy and safety of tozorakimab, a monoclonal antibody that neutralises IL-33, in improving outcomes in ACCORD-2 (EudraCT: 2020-001736-95)…